> top > docs > PubMed:24850468 > annotations

PubMed:24850468 JSONTXT

Annnotations TAB JSON ListView MergeView

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 386-391 HP_0002664 denotes tumor

Allie

Id Subject Object Predicate Lexical cue
SS1_24850468_2_0 253-306 expanded denotes Assessment of SpondyloArthritis international Society
SS2_24850468_2_0 308-312 abbr denotes ASAS
SS1_24850468_2_1 381-407 expanded denotes anti-tumor necrosis factor
SS2_24850468_2_1 409-412 abbr denotes TNF
SS1_24850468_2_2 450-467 expanded denotes spondyloarthritis
SS2_24850468_2_2 469-472 abbr denotes SpA
SS1_24850468_11_0 1400-1416 expanded denotes anterior uveitis
SS2_24850468_11_0 1418-1420 abbr denotes AU
AE1_24850468_2_0 SS1_24850468_2_0 SS2_24850468_2_0 abbreviatedTo Assessment of SpondyloArthritis international Society,ASAS
AE1_24850468_2_1 SS1_24850468_2_1 SS2_24850468_2_1 abbreviatedTo anti-tumor necrosis factor,TNF
AE1_24850468_2_2 SS1_24850468_2_2 SS2_24850468_2_2 abbreviatedTo spondyloarthritis,SpA
AE1_24850468_11_0 SS1_24850468_11_0 SS2_24850468_11_0 abbreviatedTo anterior uveitis,AU

Wangshuguang

Id Subject Object Predicate Lexical cue
T1 168-177 B-Molecular_Activity denotes adherence
T2 413-419 B-Variation denotes -alpha
T3 420-426 I-Variation denotes agents
T4 488-495 B-Variation denotes project
T5 658-668 B-Variation denotes evaluation
T6 744-755 B-Molecular_Activity denotes therapeutic
T7 756-764 I-Molecular_Activity denotes approach
T8 937-941 B-Variation denotes case
T9 942-945 I-Variation denotes for
T10 946-956 I-Variation denotes diagnostic
T11 1043-1048 B-Molecular_Activity denotes score
T12 1177-1186 B-Variation denotes agreement
T13 1197-1211 B-Interaction denotes classification
T14 1212-1220 I-Interaction denotes criteria
T15 1325-1336 B-Variation denotes improvement
T16 1511-1519 B-Variation denotes antibody
T17 1861-1865 B-Molecular_Activity denotes role

123123123

Id Subject Object Predicate Lexical cue
T1 168-177 B-Molecular_Activity denotes adherence
T2 413-419 B-Variation denotes -alpha
T3 420-426 I-Variation denotes agents
T4 488-495 B-Variation denotes project
T5 658-668 B-Variation denotes evaluation
T6 744-755 B-Molecular_Activity denotes therapeutic
T7 756-764 I-Molecular_Activity denotes approach
T8 937-941 B-Variation denotes case
T9 942-945 I-Variation denotes for
T10 946-956 I-Variation denotes diagnostic
T11 1043-1048 B-Molecular_Activity denotes score
T12 1177-1186 B-Variation denotes agreement
T13 1197-1211 B-Interaction denotes classification
T14 1212-1220 I-Interaction denotes criteria
T15 1325-1336 B-Variation denotes improvement
T16 1511-1519 B-Variation denotes antibody
T17 1861-1865 B-Molecular_Activity denotes role